Wall Street Journal: Dutch healthcare giant now expects recall to affect around 5.2 million CPAP devices, says supply-chain woes have weighed on sales.

Royal Philips NV expanded the reach of its already huge recall of breathing-aid machines and said supply-chain strains would hit fourth-quarter sales, sending shares down 15%.

The Dutch healthcare giant initiated a recall last year of certain sleep-apnea and ventilator machines amid concerns that a type of foam used in the devices could degrade and release harmful, possibly cancer-causing particles. At the time it estimated the recall would affect 3 to 4 million devices but on Wednesday it raised that estimate to 5.2 million devices world-wide. That is because it has widened the scope of the recall to include older devices after receiving requests from customers for replacements or repairs for them.

Get the full story at wsj.com.